Two Bundibugyo‑Targeted Ebola Vaccines to Begin Phase‑2 Trials in DRC
Oxford‑Moderna and Oxford‑Serum Institute candidates will start Phase‑2 testing in Bunia next week, marking a key step against the Bundibugyo Ebola strain.
Full story
Read the full story at Kenya Today ↗
Continue reading this story on Kenya Today, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.